| Date Filed | Type | Description |
| 10/04/2023 |
4
| Bellon Christine (Chief Legal Officer) has filed a Form 4 on Beam Therapeutics Inc.|
Txns:
| Sold 388 shares
@ $22.85, valued at
$8.9k
|
|
| 08/09/2023 |
4
| Simon Amy (Chief Medical Officer) has filed a Form 4 on Beam Therapeutics Inc.|
Txns:
| Sold 391 shares
@ $30.48, valued at
$11.9k
|
|
| 08/08/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 08/08/2023 |
8-K
| Results of Operations and Financial Condition, Financial Statements and Exhibits Interactive Data |
| 07/25/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/21/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/08/2023 |
4
| Burow Kristina (Director) has filed a Form 4 on Beam Therapeutics Inc.|
Txns:
| Granted 16,532 options to buy
@ $34.33, valued at
$567.5k
|
|
| 06/08/2023 |
4
| COOPER GRAHAM K (Director) has filed a Form 4 on Beam Therapeutics Inc.|
Txns:
| Granted 16,532 options to buy
@ $34.33, valued at
$567.5k
|
|
| 06/08/2023 |
4
| Walsh Kathleen E (Director) has filed a Form 4 on Beam Therapeutics Inc.|
Txns:
| Granted 16,532 options to buy
@ $34.33, valued at
$567.5k
|
|
| 06/08/2023 |
4
| Fishman Mark (Director) has filed a Form 4 on Beam Therapeutics Inc.|
Txns:
| Granted 16,532 options to buy
@ $34.33, valued at
$567.5k
|
|
| 06/08/2023 |
4
| Ho Carole (Director) has filed a Form 4 on Beam Therapeutics Inc.|
Txns:
| Granted 16,532 options to buy
@ $34.33, valued at
$567.5k
|
|
| 06/08/2023 |
4
| MARAGANORE JOHN (Director) has filed a Form 4 on Beam Therapeutics Inc.|
Txns:
| Granted 16,532 options to buy
@ $34.33, valued at
$567.5k
|
|
| 06/08/2023 |
8-K
| Submission of Matters to a Vote of Security Holders Interactive Data |
| 05/10/2023 |
424B5
| Form 424B5 - Prospectus [Rule 424(b)(5)]: |
| 05/10/2023 |
8-K
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits Interactive Data |
| 05/10/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 05/10/2023 |
8-K
| Results of Operations and Financial Condition, Financial Statements and Exhibits Interactive Data |
| 04/21/2023 |
ARS
| Form ARS - Annual Report to Security Holders: |
| 04/21/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 04/21/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 04/19/2023 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 04/05/2023 |
4
| Evans John M. (CEO) has filed a Form 4 on Beam Therapeutics Inc.|
Txns:
| Sold 5,161 shares
@ $30.31, valued at
$156.4k
Sold 6,493 shares
@ $29.0935, valued at
$188.9k
|
|
| 04/05/2023 |
4
| Ciaramella Giuseppe (President & CSO) has filed a Form 4 on Beam Therapeutics Inc.|
Txns:
| Sold 1,918 shares
@ $30.31, valued at
$58.1k
Sold 1,754 shares
@ $29.0929, valued at
$51k
|
|
| 04/05/2023 |
4
| Bellon Christine (Chief Legal Officer) has filed a Form 4 on Beam Therapeutics Inc.|
Txns:
| Sold 931 shares
@ $30.31, valued at
$28.2k
Sold 1,161 shares
@ $29.0931, valued at
$33.8k
|
|
| 04/05/2023 |
4
| Simon Amy (Chief Medical Officer) has filed a Form 4 on Beam Therapeutics Inc.|
Txns:
| Sold 4,445 shares
@ $30.31, valued at
$134.7k
Sold 10,493 shares
@ $29.7664, valued at
$312.3k
Sold 1,161 shares
@ $29.0926, valued at
$33.8k
|
|
| 04/05/2023 |
4
| Burrell Terry-Ann (CFO) has filed a Form 4 on Beam Therapeutics Inc.|
Txns:
| Sold 2,454 shares
@ $30.31, valued at
$74.4k
Sold 2,186 shares
@ $29.0931, valued at
$63.6k
|
|
| 03/31/2023 |
4
| Bellon Christine (Chief Legal Officer) has filed a Form 4 on Beam Therapeutics Inc.|
Txns:
| Granted 17,500 shares
@ $0
Exercised 6,272 options to buy
@ $7.22, valued at
$45.3k
Exercised 2,669 options to buy
@ $7.22, valued at
$19.3k
|
|
| 03/31/2023 |
4
| Ciaramella Giuseppe (President & CSO) has filed a Form 4 on Beam Therapeutics Inc.|
Txns:
| Granted 20,000 shares
@ $0
Granted 40,000 options to buy
@ $43.45, valued at
$1.7M
|
|
| 03/31/2023 |
4
| Evans John M. (CEO) has filed a Form 4 on Beam Therapeutics Inc.|
Txns:
| Small acquisition of 225 shares
@ $0
Granted 56,250 shares
@ $0
Granted 112,500 options to buy
@ $43.45, valued at
$4.9M
Exercised 13,850 options to buy
@ $7.22, valued at
$100k
|
|
| 03/31/2023 |
4
| Simon Amy (Chief Medical Officer) has filed a Form 4 on Beam Therapeutics Inc.|
Txns:
| Granted 20,000 shares
@ $0 |
|
| 03/31/2023 |
4
| Burrell Terry-Ann (CFO) has filed a Form 4 on Beam Therapeutics Inc.|
Txns:
| Granted 20,000 shares
@ $0
Granted 20,000 options to buy
@ $43.45, valued at
$869k
|
|
| 03/27/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 03/27/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 03/17/2023 |
SC 13G
| Temasek Holdings Ltd reports a 5% stake in Beam Therapeutics Inc. |
|